2. Ghadirian P, Simard A, Baillargeon J: Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case-control study in Quebec, Canada. Cancer 1991; 67: 2664-2670

3. Mack TM, Yu MC, Hanish R, et al: Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 1986; 76: 49-60

4. Canadian Task Force on the Periodic Health Examination: The periodic health examination: 2. 1985 update. Can Med Assoc J 1986; 134: 724-727

5. Rose G, Hamilton PJ, Colwell L, et al: A randomized controlled trial of anti-smoking advice: 10 year results. J Epidemiol Community Health 1982; 36: 102-108

6. Wilson D, Wood G, Johnston N, et al: Randomized clinical trial of supportive follow-up for cigarette smokers in a family practice. Can Med Assoc J 1982; 126: 127-129

7. Boyle P, Hsieh CC, Maisonneuve P, et al: Epidemiology of pancreas cancer (1988). Int J Pancreatol 1989; 5: 327-346

8. Tsuchiya R, Tsunoda T, Ishida T, et al: Resection for cancer of the pancreas--the Japanese experience. Baillieres Clin Gastroenterol 1990; 4: 931-939

9. Kalser MH, Ellenberg SS: Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120: 899-903

10. U.S. Department of Health and Human Services: The Health Benefits of Smoking Cessation. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. [DHHS Publication No.(CDC) 90-8416], 1990; 155-159

11. Homma T, Tsuchiya R: The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in Japan, using CA19-9 and elastase-1 or ultrasonography. Int J Pancreatol 1991; 9: 119-124

12. Farrow DC, Davis S: Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int J Cancer 1990; 45: 816-820

13. Nix GA, Dubbelman C, Wilson JH, et al: Prognostic implications of tumor diameter in carcinoma of the head of the pancreas. Cancer 1991; 67: 529-535

14. Del Villano BC, Brennan S, Brock P, et al: Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem 1983; 29: 549-552

15. Ritts RE Jr, Del Villano BC, Go VL, et al: Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank. Int J Cancer 1984; 33: 339-345

16. Fabris C, Del Favero G, Basso D, et al: Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approach. Am J Gastroenterol 1988; 83: 549-553

17. Frebourg T, Bercoff E, Manchon N, et al: The evaluation of CA 19-9 antigen level in the early detection of pancreatic cancer. A prospective study of 866 patients. Cancer 1988; 62: 2287-2290

18. Hirayama T: Epidemiology of pancreatic cancer in Japan. Jpn J Clin Oncol 1989; 19: 208-215

19. Olsen GW, Mandel JS, Gibson RW, et al: A case-control study of pancreatic cancer and cigarettes, alcohol, coffee and diet. Am J Public Health 1989; 79: 1016-1019

20. U.S. Preventive Services Task Force: Guide to Clinical Preventive Services: an Assessment of the Effectiveness of 169 Interventions, Williams & Wilkins, Baltimore, Md, 1989: 87-88